Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines

INTRODUCTION: Since December 2020, three COVID-19 vaccines have been authorized in the United States (U.S.) and were proceeded by large immunization programs. The aim of this study was to characterize the U.S. post-marketing safety (PMS) profiles of these vaccines with an in-depth analysis of mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Albalawi, Omar M., Alomran, Maha I., Alsagri, Ghada M., Althunian, Turki A., Alshammari, Thamir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719360/
https://www.ncbi.nlm.nih.gov/pubmed/35002372
http://dx.doi.org/10.1016/j.jsps.2021.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719360/
https://www.ncbi.nlm.nih.gov/pubmed/35002372
http://dx.doi.org/10.1016/j.jsps.2021.12.008

Ejemplares similares